表紙:先進的ドラッグデリバリーの世界市場:産業分析、動向、市場規模、2027年までの予測
市場調査レポート
商品コード
1063711

先進的ドラッグデリバリーの世界市場:産業分析、動向、市場規模、2027年までの予測

Advanced Drug Delivery Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

出版日: | 発行: Infinium Global Research (IGR) | ページ情報: 英文 100 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
先進的ドラッグデリバリーの世界市場:産業分析、動向、市場規模、2027年までの予測
出版日: 2022年02月25日
発行: Infinium Global Research (IGR)
ページ情報: 英文 100 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の先進的ドラッグデリバリーの市場規模は予測期間中に4.37%のCAGRで成長すると予想されています。市場を牽引する主な要因には慢性疾患の増加や各種疾患による医療費の増加などがあります。しかし動脈硬化治療薬の副作用や政府の厳しい規則や規制が市場を妨げる要因になります。また、先進的な研究開発は市場に機会をもたらすでしょう。

当レポートでは世界の先進的ドラッグデリバリー市場を調査し、市場の予測と概要、市場の促進要因・抑制要因の分析、COVID-19の影響、タイプ別、用途別、技術別、地域別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

  • レポートの説明
  • 調査方法
  • 調査アプローチ

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 市場の予測
  • 市場の地域的ハイライト

第3章 世界の先進的ドラッグデリバリー市場:概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 市場に対するCOVID-19の影響分析
  • ポーターのファイブフォース分析
  • IGR-成長マトリックス分析
    • タイプ別
    • 用途別
    • 技術別
    • 地域別
  • 市場のバリューチェーン分析

第4章 先進的ドラッグデリバリー市場:マクロ指標分析

第5章 世界の先進的ドラッグデリバリー市場:タイプ別

  • 経口
  • 注射型
  • 吸入/肺
  • 経皮
  • キャリア型
  • その他

第6章 世界の先進的ドラッグデリバリー市場:用途別

  • 心血管疾患
  • 腫瘍
  • 泌尿器
  • 糖尿病
  • 中枢神経系
  • 眼科
  • 感染症
  • その他

第7章 世界の先進的ドラッグデリバリー市場:技術別

  • プロドラッグ
  • インプラントと子宮内避妊器具
  • 標的化ドラッグデリバリー
  • 高分子ドラッグデリバリー
  • その他

第8章 世界の先進的ドラッグデリバリー市場(2021年~2027年):地域別

  • 北米
    • タイプ別
    • 用途別
    • 技術別
    • 国別
  • 欧州
    • タイプ別
    • 用途別
    • 技術別
    • 国別
  • アジア太平洋地域
    • タイプ別
    • 用途別
    • 技術別
    • 国別
  • その他の地域
    • タイプ別
    • 用途別
    • 技術別
    • サブリージョン別

第9章 企業プロファイルと競合情勢

  • 競合情勢
  • 企業プロファイル
    • Pfizer Inc.
    • AstraZeneca
    • Becton, Dickinson and Company
    • Abbott Laboratories
    • Amgen Inc.
    • Novartis AG
    • Baxter International
    • Bayer AG
    • Medtronic
    • Kindeva Drug Delivery L.P.
目次
Product Code: HC08746

The report on the global advanced drug delivery market provides qualitative and quantitative analysis for the period from 2019 to 2027. The report predicts the global advanced drug delivery market to grow with a CAGR of 4.37% over the forecast period from 2021-2027. The study on advanced drug delivery market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.

The report on advanced drug delivery market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global advanced drug delivery market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global advanced drug delivery market over the period of 2019 to 2027. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Rising prevalence of chronic diseases
  • Increasing healthcare expenditure due to various disease

2) Restraints

  • Side effects atherosclerosis drugs
  • Stringent government rules and regulations

3) Opportunities

  • Advanced research and development

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include:

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global advanced drug delivery market is segmented on the basis of type, application, and technology.

The Global Advanced Drug Delivery Market by Type

  • Oral Drug Delivery System
  • Injection-based Drug Delivery System
  • Inhalation/Pulmonary Drug Delivery System
  • Transdermal Drug Delivery System
  • Transmucosal Drug Delivery System
  • Carrier-based Drug Delivery System
  • Other Types

The Global Advanced Drug Delivery Market by Application

  • Cardiovascular Diseases
  • Oncology
  • Urology
  • Diabetes
  • Central Nervous System
  • Ophthalmology
  • Infections
  • Other Applications

The Global Advanced Drug Delivery Market by Technology

  • Prodrug
  • Implants and Intrauterine Devices
  • Targeted Drug Delivery
  • Polymeric Drug Delivery
  • Other Technologies

Company Profiles

The companies covered in the report include:

  • Pfizer Inc.
  • AstraZeneca
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Amgen Inc.
  • Novartis AG
  • Baxter International
  • Bayer AG
  • Medtronic
  • Kindeva Drug Delivery L.P.

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the advanced drug delivery market.

2. Complete coverage of all the segments in the advanced drug delivery market to analyze the trends, developments in the global market and forecast of market size up to 2027.

3. Comprehensive analysis of the companies operating in the global advanced drug delivery market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Advanced Drug Delivery Market Highlights
  • 2.2. Advanced Drug Delivery Market Projection
  • 2.3. Advanced Drug Delivery Market Regional Highlights

3. Global Advanced Drug Delivery Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Advanced Drug Delivery Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Type
    • 3.5.2. IGR-Growth Matrix Analysis by Application
    • 3.5.3. IGR-Growth Matrix Analysis by Technology
    • 3.5.4. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Advanced Drug Delivery Market

4. Advanced Drug Delivery Market Macro Indicator Analysis

5. Global Advanced Drug Delivery Market by Type

  • 5.1. Oral Drug Delivery System
  • 5.2. Injection-based Drug Delivery System
  • 5.3. Inhalation/Pulmonary Drug Delivery System
  • 5.4. Transdermal Drug Delivery System
  • 5.5. Carrier-based Drug Delivery System
  • 5.6. Other Types

6. Global Advanced Drug Delivery Market by Application

  • 6.1. Cardiovascular Diseases
  • 6.2. Oncology
  • 6.3. Urology
  • 6.4. Diabetes
  • 6.5. Central Nervous System
  • 6.6. Ophthalmology
  • 6.7. Infections
  • 6.8. Other Applications

7. Global Advanced Drug Delivery Market by Technology

  • 7.1. Prodrug
  • 7.2. Implants and Intrauterine Devices
  • 7.3. Targeted Drug Delivery
  • 7.4. Polymeric Drug Delivery
  • 7.5. Other Technologies

8. Global Advanced Drug Delivery Market by Region 2021-2027

  • 8.1. North America
    • 8.1.1. North America Advanced Drug Delivery Market by Type
    • 8.1.2. North America Advanced Drug Delivery Market by Application
    • 8.1.3. North America Advanced Drug Delivery Market by Technology
    • 8.1.4. North America Advanced Drug Delivery Market by Country
  • 8.2. Europe
    • 8.2.1. Europe Advanced Drug Delivery Market by Type
    • 8.2.2. Europe Advanced Drug Delivery Market by Application
    • 8.2.3. Europe Advanced Drug Delivery Market by Technology
    • 8.2.4. Europe Advanced Drug Delivery Market by Country
  • 8.3. Asia-Pacific
    • 8.3.1. Asia-Pacific Advanced Drug Delivery Market by Type
    • 8.3.2. Asia-Pacific Advanced Drug Delivery Market by Application
    • 8.3.3. Asia-Pacific Advanced Drug Delivery Market by Technology
    • 8.3.4. Asia-Pacific Advanced Drug Delivery Market by Country
  • 8.4. RoW
    • 8.4.1. RoW Advanced Drug Delivery Market by Type
    • 8.4.2. RoW Advanced Drug Delivery Market by Application
    • 8.4.3. RoW Advanced Drug Delivery Market by Technology
    • 8.4.4. RoW Advanced Drug Delivery Market by Sub-region

9. Company Profiles and Competitive Landscape

  • 9.1. Competitive Landscape in the Global Advanced Drug Delivery Market
  • 9.2. Companies Profiles
    • 9.2.1. Pfizer Inc.
    • 9.2.2. AstraZeneca
    • 9.2.3. Becton, Dickinson and Company
    • 9.2.4. Abbott Laboratories
    • 9.2.5. Amgen Inc.
    • 9.2.6. Novartis AG
    • 9.2.7. Baxter International
    • 9.2.8. Bayer AG
    • 9.2.9. Medtronic
    • 9.2.10. Kindeva Drug Delivery L.P.